Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Editas names Bosley CEO

June 25, 2014 12:24 AM UTC

Genome editing company Editas Medicine (Cambridge, Mass.) hired Katrine Bosley as CEO. She was CEO of Avila Therapeutics Inc., which Celgene Corp. (NASDAQ:CELG) acquired in 2012. Bosley succeeds Kevin Bitterman, a partner at Editas investor Polaris Partners who was serving as interim president. Editas secured $43 million in a tranched series A round last year from Polaris; Flagship Ventures; and Third Rock Ventures. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article